SIC
OM icon

SJS Investment Consulting’s Outset Medical OM Stock Holding History

SJS Investment Consulting’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264 Buy
61
+22
+56% +$96 ﹤0.01% 2422
2026
Q1 		$150 Buy
+39
New +$160 ﹤0.01% 2049
2022
Q4 		– Sell
-1
Closed – – 1670
2022
Q3 		$0 Buy
+1
New +$268 ﹤0.01% 1403

Other funds holding OM

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CFM
Catalyst Funds Management Sydney NSW, Australia $1.78B AUM 107.3% 1-Year Est. Return

SJS Investment Consulting's OM Position: Q2 2026 in Review

SJS Investment Consulting increased its Outset Medical (OM) stake by 56% in Q2 2026, buying an estimated $96 and bringing the position to 61 shares worth $264. The position accounts for ﹤0.01% of the portfolio, ranked #2422.

SJS Investment Consulting first reported a position in OM in Q3 2022 and has held it in 3 quarters since. 34 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • SJS Investment Consulting held 61 shares of Outset Medical worth $264 as of Q2 2026.
  • SJS Investment Consulting bought 22 Outset Medical shares in Q2 2026, an estimated $96.
  • Outset Medical made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2422 holding.
  • SJS Investment Consulting first reported a position in Outset Medical in Q3 2022 and has held it in 3 quarters since.
  • 34 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.